Ifrah Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Ifrah Financial Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,252	Closed	-$341K	–	210
2020 Q4	$341K	Sell	2,252 -58	-3%	-$8.29K	0.11%	139
2020 Q3	$313K	Sell	2,310 -41	-2%	-$5.56K	0.11%	136
2020 Q2	$321K	Sell	2,351 -84	-3%	-$10.7K	0.12%	137
2020 Q1	$262K	Sell	2,435 -987	-29%	-$114K	0.11%	136
2019 Q4	$412K	Buy	+3,422	New	+$382K	0.15%	124
2016 Q4	–	Sell	-3,891	Closed	-$375K	–	196
2016 Q3	$375K	Buy	+3,891	New	+$370K	0.15%	126
2016 Q2	–	Sell	-3,297	Closed	-$287K	–	203
2016 Q1	$287K	Sell	3,297 -114	-3%	-$10.2K	0.11%	142
2015 Q4	$385K	Sell	3,411 -15	-0.4%	-$1.63K	0.15%	121
2015 Q3	$346K	Sell	3,426 -3	-0.1%	-$360	0.14%	123
2015 Q2	$422K	Sell	3,429 -1,095	-24%	-$131K	0.16%	110
2015 Q1	$518K	Buy	4,524 +36	+0.8%	+$3.97K	0.19%	92
2014 Q4	$454K	Sell	4,488 -285	-6%	-$27.7K	0.18%	103
2014 Q3	$435K	Buy	+4,773	New	+$419K	0.17%	110

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ifrah Financial Services's IBB Position: Q1 2021 in Review

Ifrah Financial Services sold out of iShares Biotechnology ETF (IBB) in Q1 2021, closing a stake of 2,252 shares — an estimated $341K sold.

Ifrah Financial Services first reported a position in IBB in Q3 2014 and held it in 13 quarters. The position peaked at $518K in Q1 2015. 845 funds tracked by Wall St. Rank hold IBB as of Q1 2021.

Ifrah Financial Services reported no remaining iShares Biotechnology ETF position as of Q1 2021 after selling out during the quarter.
Ifrah Financial Services sold 2,252 iShares Biotechnology ETF shares in Q1 2021, an estimated $341K.
Ifrah Financial Services first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 13 quarters.
Ifrah Financial Services's iShares Biotechnology ETF position peaked at $518K in Q1 2015.
845 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2021.

Based on Ifrah Financial Services's 13F filing for Q1 2021, filed 30 Apr 2021.